Disposition of a Specific Cyclooxygenase-2 Inhibitor, Valdecoxib, in Human-Reference-Cited by-同舟云学术

Disposition of a Specific Cyclooxygenase-2 Inhibitor, Valdecoxib, in Human

Published:2002-09-01 Issue:9 Volume:30 Page:1013-1021
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Yuan Josh J.,Yang Dai-chang,Zhang Ji Y.,Bible Roy,Karim Aziz,Findlay John W. A.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference17 articles.

1. Celecoxib

2. SELECTIVE CYCLOOXYGENASE-2 INHIBITORS

3. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis

4. Reduced Risk of Upper Gastrointestinal Ulcer Complications With Celecoxib, A Novel Cox-2 Inhibitor

5. Grzesiok A Weber H Pino RZ Feelisch M (1994) Release of nitric oxide upon oxidative metabolism accounts for the vasodilator activity of Piloty's acid. in No. 8 - The Biology of Nitric Oxide Part 4 - Enzymology, Biochemistry and Immunology, eds Moncada S Feelisch M Busse R Higgs EA (Portland Press Ltd. London), pp 238–241.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Involvement of Sulfotransferase in the Mechanism of Lamotrigine-induced Skin Rash;Chemical Research in Toxicology;2023-11-03

2. Preclinical Pharmacokinetics and Metabolism of MAK683, a Clinical Stage Selective Oral Embryonic Ectoderm Development (EED) Inhibitor for Cancer Treatment;Xenobiotica;2021-11-11

3. Principles of Drug Metabolism;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

4. Flow-cell radionuclide analysis;Handbook of Radioactivity Analysis: Volume 2;2020

5. Non-cytochrome P450-mediated bioactivation and its toxicological relevance;Drug Metabolism Reviews;2016-09-20